Characteristics | n = 13 |
---|---|
Age, year | 57.6 ± 7.7 |
Gender(male: female), n | 4:9 |
Affected eye(right: left), n | 4:9 |
AL, mm | 23.39 ± 0.55 |
IOP, mmHg | 16.4 ± 2.2 |
Subtype of BRVO(Major BRVO: Macular BRVO), n | 8: 5 |
Duration of follow-up, months | 20 (5–65) |
Duration of macular edema, months | 8 (1–24) |
BCVA,ETDRS letters | 66.8 ± 8.0 |
Macular sensitivity, dB | 24.9 ± 2.7 |
CRT, µm | 242.5 ± 40.1 |
Baseline CRT, µm | 389.0 (261.5) |
Laser treatment, n | 7 |
Anti-VEGF treatment, n | 9 |
No laser or anti-VEGF treatment, n | 1 |